4//SEC Filing
Smith Ernest S. 4
Accession 0001062993-23-008322
CIK 0001205922other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:33 PM ET
Size
14.2 KB
Accession
0001062993-23-008322
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Smith Ernest S.
SVP, Research & CSO
Transactions
- Award
Stock Option (Right to Buy)
2023-03-31+40,000→ 40,000 totalExercise: $0.40Exp: 2033-03-30→ Common Stock (40,000 underlying)
Holdings
- 40,729
Stock Option (Right to Buy)
Exercise: $7.10Exp: 2025-12-22→ Common Stock (40,729 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $2.93Exp: 2031-04-02→ Common Stock (10,000 underlying) - 8,000
Stock Option (Right to Buy)
Exercise: $6.07Exp: 2030-02-24→ Common Stock (8,000 underlying) - 8,000
Stock Option (Right to Buy)
Exercise: $3.90Exp: 2029-03-14→ Common Stock (8,000 underlying) - 20,000
Stock Option (Right to Buy)
Exercise: $1.29Exp: 2032-04-01→ Common Stock (20,000 underlying) - 8,000
Common Stock
- 5,110
Stock Option (Right to Buy)
Exercise: $7.10Exp: 2025-12-23→ Common Stock (5,110 underlying)
Footnotes (5)
- [F1]Exercisable in full as of the date of this report.
- [F2]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date.
- [F3]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date.
- [F4]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date.
- [F5]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date.
Issuer
VACCINEX, INC.
CIK 0001205922
Entity typeother
Related Parties
1- filerCIK 0001747769
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 4:33 PM ET
- Size
- 14.2 KB